Abstract: 2, 4-disubstituted quilonine derivatives which have been reported as potent anti-tubercular agents. Thus, Mycobacterium tuberculosis receptor (LipB) was selected as a potential drug target and docked with these derivatives. The molecular docking evaluation showed that the binding affinities of all the derivatives range from (-3.2 and -18.5 kcal/mol). Two compounds (ligand 8 and ligand 17) of the derivatives were found to have the most promising binding affinity values (-15.4 and -18.5 kcal/mol) which were observed to be greater than recommended drug isoniazid (-14.6 kcal/mol).The findings of this research could be helpful for the design of new and more potent anti-tubercular analogs.
Introduction
Tuberculosis (TB) is among the common infectious diseases caused by bacteria which causes of death worldwide claiming many lives annually. According to an estimation, one third of the world's population is infected with Mycobacterium tuberculosis and nearly 9 million people have been exposed to this disease caused by M. tuberculosis each year [1] . Recommended drug like rifampicin, ciprofloxacin, ethambutol and isoniazid are available for curing tuberculosis. However emergence of multidrug resistant (MDR) and extensively drug resistant (XDR) tuberculosis resist current drugs and this give a big challenge towards successful treatment of tuberculosis [2] . This led to development of new therapeutics against diverse strains of M. tuberculosis [3] . New synthetized 2, 4-disubstituted quilonine derivatives have been reported to demonstrates tuberculosis inhibition activity [4] . It is very important to know which receptor in the tubercle bacillus is a good drug 1 Corresponding Author e-mail: shola4343@gmail.com target when developing and designing of novel antitubercular drugs. There are many enzymes that partake in metabolic process like the growth of the bacterium and one among them is Lipoate biosynthesis protein B (LipB).
LipB is an enzyme that participates in lipoylation; it catalyzes the transfer of endogenous octanoic acid to lipoyl domains by forming thioester bond to the 4-phosphopanthetheine cofactor of the acyl carrier protein (ACP). Lipoyl synthase (Lip A) then converts octanoyl derivatives into lipoyl derivatives. Thus it acts as the essential protein involved in activating the bacterium's metabolic activities [5] .
The advancement of computational chemistry led to new challenges of drug discovery [6] . Molecular docking is a computational approach which have been widely applied to pharmacology hypothesis and testing. It serves as a tool in drug discovery field to examine and elucidate the binding orientation of molecule (ligand) to receptor target site [7] . This technique saves resources, time and accelerate the process of developing novel compounds against multi-resistance diseases [8] .
Molecular modeling investigations were carried out with the aim of understanding the binding mode and interactions of 2, 4-disubstituted quilonine derivatives into the active site of LipB receptor.
Materials and Method

Optimization
The chemical structures of the molecules were drawn with Chemdraw ultra Version 12.0. [9] . Each molecule was first pre-optimized with the molecular mechanics (MMFF) and further reoptimize with Density functional theory (DFT) utilizing the B3LYP and 6-31G* basis set [10, 11] . The Spartan files of all the optimized molecules were then saved in PDB file format, which is the recommended input format in Ligplot version 1.4.5 and Discovery Studio Visualizer software.
Docking Procedure
The molecular docking studies were carried out between 2, 4-disubstituted quiloline derivatives and M. tuberculosis target site (LipB). The molecular structures 2, 4-disubstituted quiloline derivatives were presented Table 1 . These compounds together with their biological activities were obtained from the literature [4] . While the crystal structure of M. tuberculosis receptor (LipB) was obtained from the Protein Data Bank with code 1W66. All bound substances (ligands and cofactors) and solvent molecules associated with the receptor were removed. The prepared receptor and ligand were shown in Figure 1 . The prepared ligands were docked into the binding site of the prepared structure of LipB using Autodock Vina incorporated in Pyrx software. The docking results were then visualized and analyzed using Ligplot version 1.4.5 and Discovery Studio Visualizer software. 
Results and discussion
Molecular docking studies were carried out in order to elucidate the interactions and the binding modes between the target (LipB) and 2, 4-disubstituted quiloline derivatives as potent antimycobacterium tuberculosis. The docking results clearly show that the binding affinities of these ligands correlate with their activity values. The binding energy values for all the compounds range from (-3.2 and -18.5 kcal/mol) as reported in Table  2 Figure 4 and 5. Ligand 8 formed hydrophobic interactions with VAL97, ASP94, PRO124, GLN101, ASN121, GLY120, ASN279, SER104, GLN277, TYR276 and PRO119. Ligand 17 formed four hydrogen bonds (2.8013, 3.2704, 3.2287 and 3.2821˚A) with ARG98, ARG98, TRP103 and GLY120 of the target while hydrophobic interactions were observed TRY93, PRO124, VAL97, PRO123, ASP94, ASN121, ASP122, PRO119, GLN277, SER104, GLN101 and SER118. The recommended drugs; Isoniazid formed three hydrogen bonds (3.0558, 2.8619 and 2.9316˚A) with SER279, ALA337 and ASN277 while hydrophobic bonds were observed with GLY351, THR238, SER237, PHE241, PHE280 and PHE338. Increase in number of hydrogen bonds observed in ligand 8 and 17 accounts for their high binding affinities (-15.4 and -18.5 kcal/mol) compared to the recommended drugs; Isoniazid (-14.6 kcal/mol).
Ligand 8 formed a total of four hydrogen bonds with active site of LipB. The C=O of the ligand acts as hydrogen acceptor and formed two hydrogen bonds with ARG98 of the target. The N-H group (hydrazine) of the ligand acts as hydrogen donor and formed two hydrogen bonds with SER118 and TRP103 of the target. Ligand 17 formed a total of five hydrogen bonds with binding site of LipB. The C=O of the ligand also acts as hydrogen acceptor and formed two hydrogen bonds with ARG98 of the target. The N-H group (hydrazine) of the ligand acts as hydrogen donor and formed two hydrogen bonds with GLY 120 and TRP103 of the target. The hydrogen bond formation alongside with the hydrophobic interaction provide an evidence that ligand 8 and 17 are can be hit inhibitors for LipB receptor. Elucidations of hydrogen donor and hydrogen acceptor region were shown in Figure 6 and 7. 
Conclusion
Molecular docking evaluation was carried out on series of 2, 4-disubstituted quilonine derivatives as potent inhibitor against Mycobacterium tuberculosis target (LipB). Two compounds (ligand 8 and ligand 17) were found to have the most promising binding energy values (-15.4 and -18.5 kcal/mol) which were to be greater than recommended drug isoniazid (-14.6 kcal/mol). It's concluded that compound 8 and 17 could serve as potent anti-tubercular hit molecules and can be improve by structure base design.
